Development of Nanofibers with Embedded Liposomes Containing an Immunomodulatory Drug Using Green Electrospinning.

MADLS analysis TEM alginate green electrospinning immunomodulation in vitro safety liposomes in nanofibers simvastatin wound dressing

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
14 Apr 2023
Historique:
received: 21 03 2023
revised: 07 04 2023
accepted: 11 04 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

Conventional treatments for chronic wounds are often ineffective, thus new therapeutic approaches are needed, such as the delivery of immunomodulatory drugs that can reduce inflammation, restore immune cell function, and facilitate tissue regeneration. A potential drug for such an approach is simvastatin, which has major drawbacks including poor solubility and chemical instability. With the aim of developing a dressing for wound healing, simvastatin and an antioxidant were incorporated into alginate/poly(ethylene oxide) nanofibers by green electrospinning without the use of organic solvents, thanks to their prior encapsulation into liposomes. The composite liposome-nanofiber formulations exhibited fibrillar morphology (160-312 nm) and unprecedentedly high phospholipid and drug content (76%). Transmission electron microscopy revealed dried liposomes as bright ellipsoidal spots homogeneously distributed over the nanofibers. After nanofiber hydration, the liposomes reconstituted in two size populations (~140 and ~435 nm), as revealed by cutting-edge MADLS

Identifiants

pubmed: 37111731
pii: pharmaceutics15041245
doi: 10.3390/pharmaceutics15041245
pmc: PMC10143873
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Slovenian Research Agency
ID : P1-0189
Organisme : Slovenian Research Agency
ID : P2-0089
Organisme : Slovenian Research Agency
ID : J1-9194
Organisme : Slovenian Research Agency
ID : J2-3043
Organisme : Slovenian Research Agency
ID : J7-4418

Références

Int J Pharm. 2019 May 1;562:172-179
pubmed: 30898638
Polymers (Basel). 2019 Apr 16;11(4):
pubmed: 30995752
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):689-98
pubmed: 23791682
Wound Repair Regen. 2006 Nov-Dec;14(6):647-8
pubmed: 17199830
Nanomaterials (Basel). 2019 Apr 24;9(4):
pubmed: 31022935
J Control Release. 2019 Dec 28;316:223-235
pubmed: 31669567
Lancet. 2008 Nov 29;372(9653):1860-1862
pubmed: 19041788
Int J Pharm. 2018 Aug 25;547(1-2):303-314
pubmed: 29803794
Int J Biol Macromol. 2023 Mar 1;230:123380
pubmed: 36706885
Immunity. 1997 Mar;6(3):235-44
pubmed: 9075924
Pharmaceutics. 2021 Oct 20;13(11):
pubmed: 34834157
Int J Pharm. 2013 Oct 15;455(1-2):338-47
pubmed: 23906751
Int J Pharm. 2020 Jun 15;583:119398
pubmed: 32376441
Pharmazie. 2007 Mar;62(3):205-9
pubmed: 17416197
Br J Dermatol. 1991 Apr;124(4):333-40
pubmed: 2025554
Biomacromolecules. 2012 Apr 9;13(4):952-62
pubmed: 22401557
Wound Repair Regen. 2009 Nov-Dec;17(6):763-71
pubmed: 19903300
Kidney Int. 2003 Jan;63(1):12-23
pubmed: 12472764
Colloids Surf B Biointerfaces. 2018 May 5;169:60-71
pubmed: 29747031
Colloids Surf B Biointerfaces. 2015 Oct 1;134:475-82
pubmed: 25819464
Pharm Res. 1990 Mar;7(3):289-92
pubmed: 2339104
Vaccines (Basel). 2021 Dec 30;10(1):
pubmed: 35062710
Res Pharm Sci. 2010 Jul;5(2):127-33
pubmed: 22049271
Pharmaceutics. 2018 Apr 02;10(2):
pubmed: 29614804
FASEB J. 2005 Apr;19(6):605-7
pubmed: 15677697
Biomolecules. 2021 May 08;11(5):
pubmed: 34066746
Mol Ther Methods Clin Dev. 2020 Oct 20;19:411-425
pubmed: 33294490
Carbohydr Polym. 2014 Oct 13;111:18-24
pubmed: 25037324
Int J Pharm. 2018 Oct 5;549(1-2):325-334
pubmed: 30075251
Colloids Surf B Biointerfaces. 2019 Dec 1;184:110553
pubmed: 31627100
Ann Clin Microbiol Antimicrob. 2012 May 07;11:13
pubmed: 22564676
Int J Pharm. 2020 Jan 5;573:118809
pubmed: 31678525
Colloids Surf B Biointerfaces. 2014 Oct 1;122:630-637
pubmed: 25130418
Adv Ther. 2017 Mar;34(3):599-610
pubmed: 28108895
Eur J Pharm Sci. 2021 Mar 1;158:105649
pubmed: 33227346
Pharmaceutics. 2023 Jan 26;15(2):
pubmed: 36839739
Expert Opin Drug Deliv. 2021 Sep;18(9):1229-1244
pubmed: 33760648

Auteurs

Luca Casula (L)

Unit of Drug Sciences, Department of Life and Environmental Sciences, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.
Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.

Anže Zidar (A)

Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.

Julijana Kristl (J)

Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.

Matjaž Jeras (M)

Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.

Slavko Kralj (S)

Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.
Department for Materials Synthesis, Jožef Stefan Institute, Jamova Cesta 39, 1000 Ljubljana, Slovenia.
Nanos SCI, Nanos Scientificae d.o.o., Teslova Ulica 30, 1000 Ljubljana, Slovenia.

Anna Maria Fadda (AM)

Unit of Drug Sciences, Department of Life and Environmental Sciences, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.

Špela Zupančič (Š)

Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.

Classifications MeSH